In our series, we genetically investigated only conventional chordomas with impaired SMARCB1/INI1 pattern expression, and in 43.2% of the feasible cases, a monoallelic co-deletion of the SMARCB1 gene and the control region was observed. The gene discussed is SMARCB1; the disease is chordoma.